Breast implant-associated anaplastic large cell lymphoma: What we can do

Aesthetic Surgery Journal

Volumn 34, Issue 6, 2014, Pages 956-958

  Reisman, Neal R ^a,b,c  

^a CHI ST LUKE S HEALTH BAYLOR ST LUKE S MEDICAL CENTER   (United States)

^b Division of Plastic Surgery   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST IMPLANT; HUMAN; LARGE CELL LYMPHOMA; PATIENT SAFETY; PLASTIC SURGEON; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; ANAPLASTIC LARGE CELL LYMPHOMA; BREAST AUGMENTATION; BREAST TUMOR;

BREAST IMPLANTATION; BREAST IMPLANTS; BREAST NEOPLASMS; HUMANS; LYMPHOMA, LARGE-CELL, ANAPLASTIC;

EID: 84905512205     PISSN: 1090820X     EISSN: 1527330X     Source Type: Journal    
DOI: 10.1177/1090820X14539700     Document Type: Review

References (8)

1. RAND Corporation. About the RAND Corporation. http://www.rand.org/about. html. Accessed May 13, 2014.
2. RAND Corporation. Are breast implants linked to a rare form of lymphoma?http://www.rand.org/pubs/research-briefs/RB9584/index1.html. Accessed May 14, 2014.
3. US Food and Drug Administration. Anaplastic large cell lymphoma (ALCL) in women with breast implants: preliminary FDA findings and analyses. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ ImplantsandProsthetics/BreastImplants/ucm239996.htm. Accessed May 14, 2014.
4. Adams WP, Bengston BP, Glicksman CA, et al. Decision and management algorithms to address patient and food and drug administration concerns regarding breast augmentation and implants. Plast Reconstr Surg. 2004 ; 114: 1252-1257
5. Nahabedian MY. Discussion: anaplastic large cell lymphoma and breast implants: results from a structured expert consultation process. Plast Reconstr Surg. 2011 ; 128: 540-642
6. Hart AM, Lechowicz MJ, Peters KK, Holden J, Carlson GW. Breast implant-associated anaplastic large cell lymphoma: report of 2 cases and review of the literature. Aesthet Surg J. 2014 ;:
7. Eaves F, Nahai F. Anaplastic large cell lymphoma and breast implants: FDA report. Aesthet Surg J. 2011 ; 31: 467-468
8. US Food and Drug Administration. FDA medical device safety communication: reports of anaplastic large cell lymphoma (ALCL) in women with breast implants. http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm240000. htm#howtoreport. Accessed May 13, 2014.